Trial Profile

Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated Atypical Hemolytic Uremic Syndrome: A Case Series

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eculizumab (Primary)
Indications Haemolytic uraemic syndrome
Focus Therapeutic Use

Most Recent Events

30 May 2020 Planned End Date changed from 15 Dec 2018 to 30 Nov 2020.
30 May 2020 Planned primary completion date changed from 15 Sep 2018 to 30 Aug 2020.
06 Jul 2018 Planned End Date changed from 15 Oct 2018 to 15 Dec 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com